» Articles » PMID: 34220923

A Novel Immune-Related Prognostic Signature in Head and Neck Squamous Cell Carcinoma

Overview
Journal Front Genet
Date 2021 Jul 5
PMID 34220923
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The immune response within the tumor microenvironment plays a key role in tumorigenesis and determines the clinical outcomes of head and neck squamous cell carcinoma (HNSCC). However, to date, very limited robust and reliable immunological biomarkers have been developed that are capable of estimating prognosis in HNSCC patients. In this study, we aimed to identify the effects of novel immune-related gene signatures (IRGs) that can predict HNSCC prognosis. Based on gene expression profiles and clinical data of HNSCC patient cohorts from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) database, a total of 439 highly variable expressed immune-related genes (including 239 upregulated and 200 downregulated genes) were identified by using differential gene expression analysis. Pathway enrichment analysis indicated that these immune-related differentially expressed genes were enriched in inflammatory functions. After process screening in the training TCGA cohort, six immune-related genes (, , , , , and ) were significantly associated with overall survival (OS) based on the LASSO Cox regression model. Integrating these genes with clinicopathological features, a multivariable model was built and suggested better performance in determining patients' OS in the testing cohort, and the independent validation cohort. In conclusion, a well-established model encompassing both immune-related gene signatures and clinicopathological factors would serve as a promising tool for the prognostic prediction of HNSCC.

Citing Articles

Seven Immune-Related Genes' Prognostic Value and Correlation with Treatment Outcome in Head and Neck Squamous Cell Carcinoma.

Mu R, Shen Y, Guo C, Zhang X, Yang H, Yang H Mediators Inflamm. 2024; 2023:8533476.

PMID: 39282247 PMC: 11401713. DOI: 10.1155/2023/8533476.


Manipulating host secreted protein gene expression: an indirect approach by HPV11/16 E6/E7 to suppress PBMC cytokine secretion.

Zhong M, Xu M, Zheng S, Cheng S, Zeng K, Huang X Virol J. 2024; 21(1):172.

PMID: 39095779 PMC: 11295672. DOI: 10.1186/s12985-024-02432-9.


In vivo cisplatin-resistant neuroblastoma metastatic model reveals tumour necrosis factor receptor superfamily member 4 (TNFRSF4) as an independent prognostic factor of survival in neuroblastoma.

Murphy C, Devis-Jauregui L, Struck R, Boloix A, Gallagher C, Gavin C PLoS One. 2024; 19(5):e0303643.

PMID: 38809883 PMC: 11135766. DOI: 10.1371/journal.pone.0303643.


Dickkopf-1 is an immune infiltration-related prognostic biomarker of head and neck squamous cell carcinoma.

Zhao C, Liu L, He Q, Li Y, Feng J, Chen Y Aging (Albany NY). 2024; 16(4):3837-3855.

PMID: 38376441 PMC: 10929804. DOI: 10.18632/aging.205563.


A novel immune-related prognostic model with surgical status to predict tumor immune cell infiltration and drug sensitivity in head and neck squamous cell carcinoma.

Wang L, Yu X, Li H, Wang C Biochem Biophys Rep. 2023; 36:101557.

PMID: 37868302 PMC: 10585349. DOI: 10.1016/j.bbrep.2023.101557.


References
1.
Thurlow J, Pena Murillo C, Hunter K, Buffa F, Patiar S, Betts G . Spectral clustering of microarray data elucidates the roles of microenvironment remodeling and immune responses in survival of head and neck squamous cell carcinoma. J Clin Oncol. 2010; 28(17):2881-8. DOI: 10.1200/JCO.2009.24.8724. View

2.
Yang S, Ji Q, Chang B, Wang Y, Zhu Y, Li D . STC2 promotes head and neck squamous cell carcinoma metastasis through modulating the PI3K/AKT/Snail signaling. Oncotarget. 2016; 8(4):5976-5991. PMC: 5351606. DOI: 10.18632/oncotarget.13355. View

3.
Vickers A, Elkin E . Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006; 26(6):565-74. PMC: 2577036. DOI: 10.1177/0272989X06295361. View

4.
She Y, Kong X, Ge Y, Yin P, Liu Z, Chen J . Immune-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma. Cancer Cell Int. 2020; 20:22. PMC: 6969412. DOI: 10.1186/s12935-020-1104-7. View

5.
Zhou G, Zhai Y, Cui Y, Zhang X, Dong X, Yang H . MDM2 promoter SNP309 is associated with risk of occurrence and advanced lymph node metastasis of nasopharyngeal carcinoma in Chinese population. Clin Cancer Res. 2007; 13(9):2627-33. DOI: 10.1158/1078-0432.CCR-06-2281. View